Dexcom announced that its G7 diabetes sensor can now link directly to a user’s Apple Watch, allowing them to track their glucose readings in real-time even if their iPhone isn’t nearby. According to ...
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that the Dexcom G7 Continuous Glucose ...
Dexcom has continued to drive access to its pioneering real-time CGM technology, launching its best-in-class G7 sensor in 16 new markets since ATTD 2023. The company’s latest sensor, Dexcom ONE+, ...
DexCom Inc. DXCM recently announced the direct connectivity of the Dexcom G7 Continuous Glucose Monitoring (CGM) system with the Apple Watch. This added feature is now available to users in the United ...
The Dexcom G7 is now the first continuous glucose monitoring (CGM) system to connect directly to Apple Watch. It enables users to access real-time glucose readings on their wrist, enhancing ...
Dexcom Inc. DXCM, a leading glucose monitor manufacturer, has enabled direct Apple Inc.’s AAPL Watch connectivity for its G7 model in the United States. What Happened: The new feature allows G7 users ...
At CES 2015, continuous glucose monitor (CGM) maker Dexcom presented a demo of what Dexcom's CGM readings would look like on the Apple Watch, according to a report from diaTribe. The app interface ...
According to Diabète Québec, type 2 diabetes is the most common form, affecting nearly 90% of those living with diabetes, and many eventually require insulin when lifestyle changes and oral ...
This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. SAN DIEGO (FOX 5/KUSI) — San Diego-based ...
Investor's Business Daily on MSN
Dexcom Stock, Down 15%, Is Haunted By Its 'Surprisingly Cautious' Outlook
Dexcom's solid third-quarter report was overshadowed Friday by its "surprisingly cautious" outlook, and Dexcom stock tumbled.
EDINBURGH, Scotland--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, announced compelling new clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback